OpenAI completes $6.6B share sale, valuing the company at $500B, reflecting strong investor confidence and positioning it as the world's most valuable private AI company.
Major insurers are reshaping their 2026 Medicare Advantage offerings amid rising medical use and cost pressure, with some narrowing their footprint and others expanding $0-premium and $0-copay options.
Trump launches probe into left-wing groups after conservative activist's assassination
OpenAI completes $6.6B share sale, valuing the company at $500B, reflecting strong investor confidence and positioning it as the world's most valuable private AI company.
Major insurers are reshaping their 2026 Medicare Advantage offerings amid rising medical use and cost pressure, with some narrowing their footprint and others expanding $0-premium and $0-copay options.
Trump launches probe into left-wing groups after conservative activist's assassination